Aspire Biopharma Holdings, Inc.
ASBPNASDAQHealthcare● Active
$6.60
$-0.05(-0.75%)
Market Cap$761455
P/E Ratio—
52W High$35
52W Low$0.11
Aspire Biopharma Holdings, Inc.（ASBP）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ASBP · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.01M | $0.00M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.01M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | ($0.00M) | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | -1.87% | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.92M | $0.14M | $0.07M | $0.18M | $0.00M |
| G&A Expenses | $17.64M | $3.09M | $1.34M | $0.98M | $0.03M |
| Total Operating Expenses | $19.35M | $3.09M | $1.34M | $0.98M | $0.03M |
| Operating Income | ($19.35M) | ($3.09M) | ($1.34M) | ($0.98M) | ($0.03M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00M | $0.55M | $5.81M | $4.32M | $0.00M |
| Interest Expense | $8.53M | ($0.89M) | $0.01M | $0.00M | $0.00M |
| Income Before Tax | ($24.48M) | ($12.54M) | $4.46M | $3.34M | ($0.03M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($24.48M) | ($12.54M) | $4.46M | $3.34M | ($0.03M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-16.38 | $-18.17 | $9.31 | $3.72 | $-0.04 |
| Wtd Avg Shares | 1.49M | 0.69M | 0.48M | 0.90M | 0.68M |
| EBITDA | ($19.35M) | ($11.65M) | $5.80M | $3.34M | ($0.03M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Aspire Biopharma Holdings, Inc.
关于Aspire Biopharma Holdings, Inc.（ASBP）损益表
Aspire Biopharma Holdings, Inc.（ASBP）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，ASBP实现营收$0.00B，毛利润($0.00B)（毛利率-1.87%），净利润($0.02B)（净利率-394725.06%）。
常见问题
ASBP · 4 问Aspire Biopharma Holdings, Inc.（ASBP）2025财年营收为$0.00B，同比up—%。
ASBP revenueASBP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09